Contract 36C25624N0388
Bayer Healthcare Pharmaceuticals Inc · Department Of Veterans Affairs · August 26, 2024
Bayer Healthcare Pharmaceuticals Inc was awarded a federal contract by Department Of Veterans Affairs on August 26, 2024 for $348,000 (current value) of work in pharmaceutical preparation manufacturing. Performance is in Dublin, OH. This is a task or delivery order issued under parent IDIQ 36F79720D0237. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 24, 2026. If all options are exercised, the contract could reach $348,000.
Contract details
- PIID
- 36C25624N0388
- Parent IDIQ
- 36F79720D0237
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Dublin, OH
- First action
- August 26, 2024
- Latest action
- March 24, 2026
Description
DEOBLIGATION OF EXCESS FUNDS FOR FY24 AND FY25 - RADIOACTIVE ISOTOPES XOFIGO
Modification timeline
-
March 24, 2026Mod P00003 · Supplemental Agreement For Work Within Scope$348.2K
-
August 26, 2024Mod P00001 · Other Administrative ActionRADIOACTIVE ISOTOPES XOFIGO$386.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C25624N0388?
Contract 36C25624N0388 is a federal contract awarded to Bayer Healthcare Pharmaceuticals Inc by Department Of Veterans Affairs on August 26, 2024 for $348,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 36C25624N0388?
Bayer Healthcare Pharmaceuticals Inc won contract 36C25624N0388 from Department Of Veterans Affairs.
How much is contract 36C25624N0388 worth?
Contract 36C25624N0388 has obligated $0 to date but carries a potential ceiling of $348,000 if fully funded and all options are exercised.